Evaluation of hemostasis parameters and the role of the oxidative damage to plasma proteins in the modulation of hemostasis in patients with nephrolithiasis before and after extracorporeal shock wave lithotripsy

• Published in: PloS one Vol. 12; no. 10; p. e0185157
• Main Authors: Woźniak, Paweł, Kontek, Bogdan, Różański, Waldemar, Olas, Beata
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 02.10.2017; Public Library of Science (PLoS)
• Subjects: Antioxidants; Biochemistry; Biology and Life Sciences; Biomarkers; Bleeding; Blood; Blood levels; Blood platelets; Blood Proteins - metabolism; Carbonyls; Care and treatment; Chronic illnesses; Damage assessment; Diagnosis; Endangered & extinct species; Environmental protection; Extracorporeal shockwave lithotripsy; Family medical history; Female; Fibrinogen; Hemorrhage; Hemostasis; Hemostatics; Humans; Kidney Calculi - metabolism; Kidney Calculi - physiopathology; Kidney Calculi - therapy; Kidney stones; Lipid peroxidation; Lithotripsy; Lithotripsy - methods; Male; Measurement methods; Medicine and Health Sciences; Mens health; Middle Aged; Nephrolithiasis; Oxidative Stress; Patients; Peroxidation; Physical Sciences; Physiological aspects; Plasma proteins; Plasmas (physics); Platelets; Proteins; Prothrombin; Risk factors; Shock waves; Thrombin; Thromboplastin; Urology; Womens health; Poland; Germany
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0185157

Extracorporeal shock wave lithotripsy (ESWL) is a commonly-used method in urology, which may modulate hemostasis and may induce lipid peroxidation in patients with nephrolithiasis. However, previous studies only examine changes occurring in patients 30-240 min after ESWL. The main aim of the present study was to determine whether oxidative stress may modulate the hemostatic activity of plasma in patients with nephrolithiasis before ESWL and the day after treatment ESWL. This will be performed by measuring selected parameters of hemostasis in these patients, both before ESWL and the following day, and assessing the level of oxidative damage to plasma proteins in these patients by measuring two biomarkers. Twelve patients with nephrolithiasis and 10 healthy participants were included. The following parameters of hemostasis were measured: the activated partial thromboplastin time (APTT), prothrombin time (PT), and thrombin time (TT) of plasma, the level of fibrinogen, the level of D-dimer and blood platelet count. In addition, two selected biomarkers of oxidative stress were measured: protein carbonylation level and the number of protein thiol groups. No difference was observed between patients with nephrolithiasis before and after ESWL and healthy controls with regard to PT, TT or APTT. Fibrinogen concentration and blood platelet count were lower in the nephrolithiasis patients in the period after ESWL than before ESWL. The nephrolithiasis patients demonstrated elevated D-dimer concentration after ESWL. However, although oxidative damage was observed in the plasma proteins in the nephrolithiasis patients, this was not influenced by ESWL. Oxidative stress may induce changes of hemostasis in patients with nephrolithiasis, both before and after ESWL. In addition, changes of hemostasis parameters such as fibrinogen, blood platelet count and D-dimer level can be observed in these patients, especially after ESWL, and this may suggest that ESWL modulates hemostasis. By having a better understanding of the influence of ESWL on hemostasis, this could lead to modifying patient care for those patients at increased risk of bleeding.